Synthesis of 1-aryl-7-substituted phthalazines as parasite cysteine protease inhibitors.

被引:0
|
作者
Vines, K
Avery, MA
Sabnis, YA
Rosenthal, PJ
机构
[1] Univ Mississippi, Sch Pharm, Dept Med Chem, University, MS 38677 USA
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
106-MEDI
引用
收藏
页码:U193 / U193
页数:1
相关论文
共 50 条
  • [1] Design and synthesis of mechanism-based cysteine protease inhibitors.
    Huang, L
    Lee, A
    Ellman, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U118 - U118
  • [2] Structural Studies of Mycocypins, A New Family of Cysteine Protease Inhibitors.
    Renko, Miha
    Sabotic, Jerica
    Brzin, Joze
    Turk, Dusan
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S136 - S136
  • [3] PHARMACOLOGICAL STUDY OF NEW 1-ARYL SUBSTITUTED PHTHALAZINES
    ROBEV, SK
    BOYADJIEVA, NI
    DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE, 1982, 35 (11): : 1587 - 1590
  • [4] Synthesis of simple aryl neutral sphingomyelinase inhibitors.
    Chau, JN
    Pettus, TRR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U124 - U124
  • [5] Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target
    Selzer, PM
    Pingel, S
    Hsieh, I
    Ugele, B
    Chan, VJ
    Engel, JC
    Bogyo, M
    Russell, DG
    Sakanari, JA
    McKerrow, JH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11015 - 11022
  • [6] Design and synthesis of peptide hemiaminals as protease inhibitors.
    Ross, TM
    Malachowski, WP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U953 - U953
  • [7] A new method for the synthesis of 1-aryl phthalazines
    Shashikanth, S
    Ahmad, SK
    Hegde, GL
    Rai, KML
    SYNTHETIC COMMUNICATIONS, 1999, 29 (20) : 3503 - 3507
  • [8] Attenuation of cathepsin K processing and turnover in osteoclasts by cysteine protease inhibitors.
    Rieman, DJ
    James, IE
    Dodds, R
    McClung, HA
    Lee-Rykaczewski, J
    Marquis, R
    Yamashita, D
    Lark, M
    Veber, D
    Drake, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S357 - S357
  • [9] 7-aryl substituted-4-anilinoquinoline-3-carbonitriles as potent MEK-1 kinase inhibitors.
    Berger, DM
    Cole, D
    Dutia, M
    Honores, E
    Powell, DW
    Feldberg, L
    Wojciechowicz, D
    Mallon, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
  • [10] Heteroarylmethyl carboxamidobenzyl substituted cyclic ureas as HIV protease inhibitors.
    Sherk, SR
    Selby, TP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 279 - MEDI